pmc logo imageJournal ListSearchpmc logo image
Logo of jzusbJournal URL: redirect3.cgi?&&auth=0Tku6JpugyC5TcLtZLHhTVfjDD0RPv0GqsZGjgQEE&reftype=publisher&artid=2528888&article-id=2528888&iid=171356&issue-id=171356&jid=371&journal-id=371&FROM=Article|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://www.zju.edu.cn/jzus
J Zhejiang Univ Sci B. 2008 September; 9(9): 728–733.
doi: 10.1631/jzus.B0820095.
PMCID: PMC2528888
Simultaneous detection of seven phenolic acids in Danshen injection using HPLC with ultraviolet detector* §
Jin-zhong Xu, Jie Shen, Yi-yu Cheng, and Hai-bin Qu
Department of Chinese Medicine Science and Engineering, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
Corresponding Author
†E-mail:quhb/at/zju.edu.cn
Received March 20, 2008; Accepted April 24, 2008.
Abstract
A high-performance liquid chromatographic (HPLC) method with ultraviolet (UV) detector had been developed for simultaneous quantification of danshensu, protocatechuic aldehyde, caffeic acid, salvianolic acid D, rosmarinic acid, salvianolic acid B and salvianolic acid A in Danshen injection. According to the UV spectra of these components, three detection wavelengths have been selected as follows: 280 nm for danshensu and protocatechuic aldehyde, 326 nm for caffeic acid, salvianolic acid D and rosmarinic acid, 286 nm for salvianolic acid B and salvianolic acid A. The limit of detection (LOD) was improved to be in the range of 0.008~0.160 μg/ml. Moreover, excellent linear behavior over the investigated concentration range was observed, with R>0.999 for all the analytes.
Keywords: High-performance liquid chromatography (HPLC), Danshen injection (DSI), Phenolic acids, Multi-wavelengths, Quantification
INTRODUCTION

Danshen (DS), the dried root of Salvia miltiorrhiza, is a famous traditional Chinese medicine and widely used to treat coronary heart disease, cerebrovascular disease, bone loss, hepatitis, hepatocirrhosis and chronic renal failure (Wasser et al., 1998; Liu et al., 2000; Ji et al., 2003; Chae et al., 2004; Ling et al., 2005). There are a number of traditional Chinese medicinal preparations containing DS, such as Danshen tablets, Danshen dripping pills, Danshen injection (DSI) and Xiangdan injection. DSI is made from the aqueous extract of DS and widely used in clinics as a treatment for coronary heart disease, heart-stroke and cerebrovascular disease.

The chemical constituents of DS include both lipophilic and hydrophilic components. The major hydrophilic components are phenolic acids including danshensu (DSS), protocatechuic aldehyde (PA), rosmarinic acid (RA) and salvianolic acids, which are also major pharmacologically active constituents in DSI. Taking the phenolic acids as target compounds, many high-performance liquid chromatographic (HPLC) methods have been established for the quality control of DS and its related traditional Chinese medicinal preparations. For instance, HPLC coupled with ultraviolet (UV) detection (Zhang et al., 2005) or diode-array detection (DAD) (Hu et al., 2005; Liu et al., 2007) together with liquid chromatography-tandem mass spectrometry (LC-MSn) method and HPLC with a coulometric electrode array system (HPLC-CEAD) (Ma et al., 2007) have been established for chemical fingerprint analysis of DS. HPLC-UV methods have been used in the quantification of both four phenolic acids and three lipophilic components in DS (Yuan et al., 2005) and seven active components including salvianolic acids, tanshinones and ginsenosides in the Fufang Danshen tablet (Wei et al., 2007). An HPLC method with photodiode-array UV detection has been developed to quantify three major lipophilic components (cryptotanshinone, tanshinone I and tanshinone IIA) and three major hydrophilic components (DSS, PA and salvianolic acid B (SaB)) (Fig.1) of DS (Zhou et al., 2006). An HPLC method with DAD has been established for simultaneous quantification of six phenolic acids (DSS, PA, RA, lithospermic acid, SaB and salvianolic acid A (SaA)) in DS and its related traditional Chinese medicinal preparations (Liu et al., 2006). All of the abovementioned papers have indicated that HPLC is a feasible method for quality control of DS and its related preparations including DSI. On the other hand, we realized that the contents of some phenolic acids, such as caffeic acid (CA) and salvianolic acid D (SaD) (Fig.1), are so low that they are difficult to be quantified.

Fig. 1Fig. 1
Chemical structures of target compounds in Danshen injection

The present study aimed at developing a more sensitive HPLC method with UV detector for simultaneous quantification of those components which are in low content in the DSI. In the analytical process three wavelengths of 280 nm, 326 nm and 286 nm have been selected to detect DSS and PA, CA, SaD and RA, SaB and SaA, respectively, and the limit of detection (LOD) was improved to be in the range of 0.008~0.160 µg/ml. This method has been applied in determining the amount of these seven compounds, from different batches and producers, in the DSI.

MATERIALS AND METHODS

Chemicals and reagents
DSIs were supplied by a Chinese pharmaceutical manufacturer (Qingchunbao, Zhejiang, China). Standard substances including DSS, PA, CA, RA and SaB were purchased from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). SaD and SaA were isolated from aqueous extract of DS. These isolated salvianolic acids were identified on the basis of mass spectrum (MS) data, purities of which were all over 97% by HPLC analysis. The HPLC-grade acetonitrile and formic acid were purchased from Merck (Darmstadt, Germany) and the Tedia Company (Fairfield, USA), respectively. Deionized water used throughout the experiments was produced using a Mill-Q academic water purification system (Milford, MA, USA).

Instrumentation and analytical conditions
The HPLC system HP 1100 series (Agilent Technologies, Waldbronn, Germany) was equipped with Chemstation Software (Agilent Technologies) and was comprised of a quaternary pump, an online vacuum degasser, an autosampler and a thermostated column compartment. A UV detector was used for the chromatographic analysis and a DAD detector was used to obtain UV spectra of seven standard substances. All separations were carried out on a Tigerkin C18 column (200 mm×4.6 mm i.d., 5.0 µm particle size) from Dalian Sipore Co., Ltd. (Dalian, China). A linear gradient elution of Eluents A (0.5% (v/v) aqueous formic acid) and B (0.5% (v/v) formic acid in acetonitrile) was used to run the separation. The elution programme was well optimized and conducted as follows: the first linear gradient was 5%~20% Eluent B in the range of 0~10 min, the second one was 20%~25% Eluent B in the range of 10~17 min, and the last one was 25%~55% Eluent B in the range of 17~35 min. Then the system was restored to initial conditions after 5 min. The solvent flow rate was 1.0 ml/min, the injection volume was 20 µl, and the column temperature was maintained at 30 °C. The chromatograms were recorded at 280 nm in the range of 0~13 min, 326 nm in the range of 13~23.5 min, and 286 nm in the range of 23.5~35 min.

Solution preparation

1. Standard solution
The standard stock solutions of DSS (4.05 mg/ml), PA (5.10 mg/ml), CA (1.0 mg/ml), SaD (1.15 mg/ml), RA (2.70 mg/ml), SaB (1.00 mg/ml) and SaA (1.10 mg/ml) were prepared in phosphoric acid-methanol-water (0.5/80/19.5, v/v/v) and stored away from light at 4 °C. Working solutions of the lower concentration were prepared by an appropriate dilution of the stock solution.

2. Sample solution
DSI of 200 µl was diluted to 1 ml with deionized water and the dilution was injected into the HPLC system.

RESULTS AND DISCUSSION

Chromatographic separation
An aqueous acetonitrile solvent system was often used in the HPLC analysis of phenolic acids in DS (Wasser et al., 1998; Liu et al., 2000; Zhang et al., 2005; Zhou et al., 2006; Ma et al., 2007) and the modifiers were formic acid, acetic acid, or phosphoric acid. Water (0.5% (v/v) formic acid) and acetonitrile (0.5% (v/v) formic acid) were selected as the mobile phases in the experiment. From the UV spectra of these seven phenolic acids (Fig.2), 280 nm for DSS and PA, 326 nm for CA, RA and SaD, and 286 nm for SaB and SaA, were selected as detective wavelengths. Five column temperatures (15, 20, 25, 30 and 35 °C) were investigated and the separation of CA, SaD and SaB was found to be improved when the temperature stepped up. However, base-line separation of DSS was obtained at 30 °C (Fig.3). As a result, the column temperature was determined as 30 °C. The most suitable flow rate was found to be 1.0 ml/min. Finally the chromatograms, after optimization of the mixture of standard solution and the real sample solution, were described as in Fig.4.
Fig. 2Fig. 2Fig. 2Fig. 2
UV spectra of six target phenolic acids from DS. (a) 280 nm for DSS and PA, (b) 326 nm for CA, SaD and RA, and (c) 286 nm for SaB and SaA were selected as detective wavelengths
Fig. 3Fig. 3
HPLC chromatograms (280 nm) obtained from using different column temperatures. The peaks marked with 1~7 were DSS, PA, CA, SaD, RA, SaB and SaA, respectively
Fig. 4Fig. 4
HPLC chromatograms at optimized conditions (280 nm in 0~13 min, 326 nm in 13~23.5 min, and 286 nm in 23.5~35 min, 1 ml/min, 30 °C). The peaks marked with 1~7 were DSS, PA, CA, SaD, RA, SaB and SaA, respectively. (a) Real sample solution; (b) Mixture (more ...)

Calibration curves and limits of detection
Integrated chromatographic peak areas (Y) were plotted against the corresponding concentrations (X, μg/ml) of the seven constituents in the standard solutions to obtain calibration curves based on linear regression analysis. The regression curves were obtained from six concentration levels and all the analytes had good linearity (R>0.999) in the investigated ranges (Table 1). Limit of quantification (LOQ) was defined as the lowest concentration level resulting in a peak height of 10 times the baseline noise (the signal-to-noise ratio (S/N) is 10). The minimum concentration, which could be calculated at S/N=3, was considered to be the LOD. The LOD values for seven target components were in the range of 0.008~0.160 µg/ml (Table 1), which were better than those (0.04~0.43 µg/ml) in a previous report (Wasser et al., 1998).
Table 1Table 1
Results of regression analysis on calibration curves and limits of detection (n=3)

Repeatability, precision and stability
The analysis repeatability was examined by using six duplicate samples from the same batch of DSI, treated according to the sample preparation procedure and analyzed with the established HPLC method. The stabilities of these seven compounds were tested at six time points (0, 2, 4, 8, 16 and 24 h) during 24 h. The result showed that DSS, PA, CA, SaD, RA and SaB were stable in the testing period, except for SaA with a stability of just 4 h (Table 2). According to this decomposing speed, it was almost certain that SaA in DSI became unstable just after opening the bottle of injections. After 4 h, the chromatographic peak of SaA in DSI had almost disappeared, while SaA in stock solution was found to be stable. It was thought to relate to their different pH values (about pH 7 in DSI and pH 3 in stock solution). The instability of SaA was thought to indicate that its relative standard deviation (RSD) value of repeatability analysis was more than 5% (Table 2).
Table 2Table 2
Repeatability and stability of the target components (n=6)

The intra- and inter-day instrument precisions were determined by analyzing three different concentration solutions (low, medium and high) of authentic standards. The intra- and inter-day experiments were tested by injecting three times in a single day and three times on six successive days, respectively. The results are shown in Table 3. Due to its instability, the maximum RSD values in the precision test were obtained from SaA.

Table 3Table 3
Analytical results of intra- and inter-day variabilities

Recovery test
In the experiment, three different quantities (low, medium and high) of authentic standards were added to sample solutions. Then the mixture solutions were analyzed using the developed HPLC-UV method mentioned above and the quantity of each component was subsequently calculated from the corresponding calibration curve. The result (Table 4) showed that the recovery of these six phenolic acids, except SaA, ranged from 94.32%~106.05%. In previous experiments, SaA was found to be unstable in DSI and relatively stable in phosphoric acid-methanol-water (stock solution). Due to this fact, the recoveries of SaA that were obtained were much higher than 100% at low concentration and lower than 100% at medium and high concentrations. These recoveries were tested from low concentration to high concentration.
Table 4Table 4
Recovery test of developed method (n=3)

Sample analysis
The developed method was applied to the simultaneous quantification of DSS, PA, CA, SaD, RA, SaB and SaA in DSIs from different batches. The result (Table 5) showed that as the unique target component for quality control of DSI, the content of PA approximated to 250 µg/ml in all of the samples, while contents of other components differed greatly among batches from the same company. The variety may result from the low level of quality standards. It is well known that the preparations of traditional Chinese medicines generally include multiple bioactive constituents while only one component (e.g. PA in DSI) was considered as the target for quality control. It meant that only the target compound was well monitored during the manufacturing process and other components were ignored.
Table 5Table 5
Determination of seven phenolic acids in DSIs by the developed HPLC method

CONCLUSION

In the present study, an HPLC method with ultraviolet detector has been developed for the simultaneous detection of seven phenolic acids of DSS, PA, CA, SaD, RA, SaB and SaA in DSI. This method was sensitive since the LOD values were improved to be in the range of 0.008~0.160 µg/ml. All of the target components were base-line separated during 27 min. This method was applied to analyze DSIs from different batches. Otherwise, SaA was found to be unstable in injections (pH 7). Therefore, the research into the transformation or degradation of SaA would be an interesting topic in future.

Footnotes
*Project supported by the National Basic Research Program (973) of China (No. 2005CB523402) and the Program for the New Century Excellent Talents in University of China (No. NCET-06-0515)
§The papers for the Postdoctoral Fellows Association of Zhejiang Province, China
References
1.
Chae, HJ; Chae, SW; Yun, DH; Keum, KS; Yoo, SK; Kim, HR. Prevention of bone loss in ovariectomized rats: the effect of Salvia miltiorrhiza extracts. Immunopharmacol Immunotoxicol. 2004;26(1):135–144. doi: 10.1081/IPH-120029951. [PubMed]
2.
Hu, P; Luo, GA; Zhao, ZZ; Jiang, ZH. Quantitative determination of four diterpenoids in Radix Salviae miltiorrhizae using LC-MS-MS. Chem Pharm Bull. 2005;53(6):705–709. doi: 10.1248/cpb.53.705. [PubMed]
3.
Ji, X; Tan, BK; Zhu, YC; Linz, W; Zhu, YZ. Comparison of cardioprotective effects using ramipril and danshen for the treatment of acute myocardial infarction in rats. Life Sci. 2003;73(11):1413–1426. doi: 10.1016/S0024-3205(03)00432-6. [PubMed]
4.
Ling, S; Dai, A; Guo, Z; Yan, X; Komesaroff, PA. Effects of a Chinese herbal preparation on vascular cells in culture: mechanisms of cardiovascular protection. Clin Exp Pharmacol Physiol. 2005;32(7):571–578. [PubMed]
5.
Liu, AH; Li, L; Xu, M; Lin, YH; Guo, HZ; Guo, DA. Simultaneous quantification of six major phenolic acids in the roots of Salvia miltiorrhiza and four related traditional Chinese medicinal preparations by HPLC-DAD method. J Pharm Biomed Anal. 2006;41(1):48–56. doi: 10.1016/j.jpba.2005.10.021. [PubMed]
6.
Liu, AH; Lin, YH; Guo, H; Guan, SH; Sun, JH; Guo, DA. Development of the fingerprints for the quality of the roots of Salvia miltiorrhiza and its related preparations by HPLC-DAD and LC-MSn . J Chromatogr B. 2007;846(1-2):32–41. doi: 10.1016/j.jchromb.2006.08.002.
7.
Liu, J; Shen, HM; Ong, CN. Salvia miltiorrhiza inhibits cell growth and induces apoptosis in human hepatoma HepG2 cells. Cancer Lett. 2000;153(1-2):85–93. doi: 10.1016/S0304-3835(00)00391-8. [PubMed]
8.
Ma, L; Zhang, X; Zhang, H; Gan, Y. Development of a fingerprint of Salvia miltiorrhiza Bunge by high-performance liquid chromatography with a coulometric electrode array system. J Chromatogr B. 2007;846(1-2):139–146. doi: 10.1016/j.jchromb.2006.08.048.
9.
Wasser, S; Ho, JMS; Hui, K; Tan, CEL. Salvia miltiorrhiza reduces experimentally-induced hepatic fibrosis in rats. J Hepatol. 1998;29(5):760–771. doi: 10.1016/S0168-8278(98)80257-2. [PubMed]
10.
Wei, YJ; Li, SL; Li, P. Simultaneous determination of seven active components of Fufang Danshen tablet by high performance liquid chromatography. Biomed Chromatogr. 2007;21(1):1–9. doi: 10.1002/bmc.700. [PubMed]
11.
Yuan, D; Pan, Y; Fu, W; Makino, T; Kano, Y. Quantitative analysis of the marker compounds in Salvia miltiorrihiza root and its phytomedicinal preparations. Chem Pharm Bull. 2005;53(5):508–514. doi: 10.1248/cpb.53.508. [PubMed]
12.
Zhang, J; Cui, M; He, Y; Yu, H; Guo, D. Chemical fingerprint and metabolic fingerprint analysis of Danshen injection by HPLC-UV and HPLC-MS methods. J Pharm Biomed Anal. 2005;36(5):1029–1035. doi: 10.1016/j.jpba.2004.09.009. [PubMed]
13.
Zhou, L; Chow, M; Zuo, Z. Improved quality control method for Danshen products—consideration of both hydrophilic and lipophilic active components. J Pharm Biomed Anal. 2006;41(3):744–750. doi: 10.1016/j.jpba.2005.12.032. [PubMed]